Cystic Fibrosis Foundation   Report issue

Foundation Phase 1 Phase 2 Phase 3 Phase 4
Founded: Philadelphia PA United States (1955)

Organization Overview

First Clinical Trial
2003
NCT00530244
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Cystic Fibrosis Foundation | Cystic Fibrosis Foundation (CFF)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Cystic Fibrosis (Phase 3)

Fibrosis (Phase 3)

Infections (Phase 2)

Lung Diseases (Phase 3)

Mycobacterium Infections (Phase 3)

Mycobacterium Infections, Nontuberculous (Phase 2)

Pseudomonas Infections (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 14
  • # of Trial APIs: 29